ADA 2022 Wrap Up: Iterative Progress On Glucose Control, No Big Surprises
Executive Summary
The major players in the diabetes tech sector announced new and re-hashed old clinical data at this year’s American Diabetes Association Scientific Sessions in New Orleans.
You may also be interested in...
Insulet Receives FDA Clearance For Omnipod For Children Ages 2 And Up
Insulet widens the launch of its Omnipod 5 automated insulin delivery system with the FDA clearance for children ages 2 and up. Previously, the system was available to people aged 6 years and older.
Building Digital Platforms To Bridge Diabetes Care Gaps
Are digital solutions the missing link for diabetes care? Glooko and Omada Health think so. Both have developed device-integrating platforms to help patients manage their condition.
Minute Insight: Abbott Touts 14-Day FreeStyle Libre 3 Data
Shortly after the FDA approved Abbott's FreeStyle Libre 3 continuous glucose monitor system, the company announced new clinical data showing that it is the most accurate 14-day CGM system available.